171 related articles for article (PubMed ID: 17058275)
1. Anabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscle.
Burniston JG; McLean L; Beynon RJ; Goldspink DF
Muscle Nerve; 2007 Feb; 35(2):217-23. PubMed ID: 17058275
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.
Burniston JG; Clark WA; Tan LB; Goldspink DF
Muscle Nerve; 2006 May; 33(5):655-63. PubMed ID: 16411205
[TBL] [Abstract][Full Text] [Related]
3. beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle.
Burniston JG; Tan LB; Goldspink DF
J Appl Physiol (1985); 2005 Apr; 98(4):1379-86. PubMed ID: 15591297
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
[TBL] [Abstract][Full Text] [Related]
5. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
Bricout VA; Serrurier BD; Bigard AX
Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
[TBL] [Abstract][Full Text] [Related]
6. The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.
Cancelliero KM; Durigan JL; Vieira RP; Silva CA; Polacow ML
Braz J Med Biol Res; 2008 Dec; 41(12):1054-8. PubMed ID: 19148366
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of dexamethasone and clenbuterol on rat growth and on beta2-adrenoceptors in lung and skeletal muscle.
Huang H; Gazzola C; Pegg GG; Sillence MN
J Anim Sci; 2000 Mar; 78(3):604-8. PubMed ID: 10764067
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.
Plant DR; Kearns CF; McKeever KH; Lynch GS
J Muscle Res Cell Motil; 2003; 24(7):471-6. PubMed ID: 14677650
[TBL] [Abstract][Full Text] [Related]
9. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
[TBL] [Abstract][Full Text] [Related]
10. Myotoxic effects of clenbuterol in the rat heart and soleus muscle.
Burniston JG; Ng Y; Clark WA; Colyer J; Tan LB; Goldspink DF
J Appl Physiol (1985); 2002 Nov; 93(5):1824-32. PubMed ID: 12381771
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
Murphy RJ; Béliveau L; Gardiner PF; Calderone A
Proc Soc Exp Biol Med; 1999 Jul; 221(3):184-7. PubMed ID: 10404034
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats].
Rehfeldt C; Weikard R; Reichel K
Arch Tierernahr; 1994; 45(4):333-44. PubMed ID: 7487480
[TBL] [Abstract][Full Text] [Related]
13. Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment.
von Deutsch DA; Abukhalaf IK; Wineski LE; Silvestrov NA; Bayorh MA; Potter DE
Can J Physiol Pharmacol; 2003 Jan; 81(1):28-39. PubMed ID: 12665255
[TBL] [Abstract][Full Text] [Related]
14. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
Mounier R; Cavalié H; Lac G; Clottes E
Pflugers Arch; 2007 Jan; 453(4):497-507. PubMed ID: 17093970
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat.
Rajab P; Fox J; Riaz S; Tomlinson D; Ball D; Greenhaff PL
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1076-81. PubMed ID: 10956268
[TBL] [Abstract][Full Text] [Related]
16. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
Suzuki J; Gao M; Xie Z; Koyama T
Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
[TBL] [Abstract][Full Text] [Related]
17. Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
Py G; Ramonatxo C; Sirvent P; Sanchez AM; Philippe AG; Douillard A; Galbès O; Lionne C; Bonnieu A; Chopard A; Cazorla O; Lacampagne A; Candau RB
J Physiol; 2015 Apr; 593(8):2071-84. PubMed ID: 25656230
[TBL] [Abstract][Full Text] [Related]
18. The effects of intraperitoneal clenbuterol injection on protein degradation and myostatin expression differ between the sartorius and pectoral muscles of neonatal chicks.
Ijiri D; Ishitani K; Shimamoto S; Ishimaru Y; Ohtsuka A
Gen Comp Endocrinol; 2014 Sep; 206():111-7. PubMed ID: 25117456
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis.
Tonge DP; Jones SW; Parr T; Bardsley R; Doherty M; Maciewicz RA
Osteoarthritis Cartilage; 2010 Apr; 18(4):555-62. PubMed ID: 20060953
[TBL] [Abstract][Full Text] [Related]
20. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist.
Abo T; Iida RH; Kaneko S; Suga T; Yamada H; Hamada Y; Yamane A
Cell Biochem Funct; 2012 Dec; 30(8):671-6. PubMed ID: 22696074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
